AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Glibenclamide in Zambia
3 products registered with ZAMRA — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Diolin tablets Tablet Uncoated | 228/009 | Lincoln Pharmaceuticals Limited | active | 24 Jan 2030 |
| Glamide 5mg tablets Tablet Uncoated | 113/028 | Cadila Pharmaceuticals Limited | active | 5 Jun 2029 |
| Kaonil tablets Tablet Uncoated | 098/007 | Kamal International | active | 2 Jun 2029 |
Glibenclamide — ZAMRA Registration Details
ZAMRA (Zambia) has 3 registered products containing Glibenclamide, of which 3 are currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Glibenclamide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.